Ultraschall Med 2019; 40(05): 609-617
DOI: 10.1055/a-0583-8254
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Good Agreement Between Transabdominal and Endoscopic Ultrasound of the Pancreas in Chronic Pancreatitis

Gute Übereinstimmung des transabdominalen und endoskopischen Ultraschalls der Bauchspeicheldrüse bei chronischer Pankreatitis
Trond Engjom
1   Department of Medicine, Haukeland Universitetssjukehus, Bergen, Norway
,
Khahn Do-Chong Pham
2   Department of Clinical Medicine, University of Bergen, Norway
,
Friedemann Erchinger
3   Department of Clinical Medicine, Universitetet i Bergen Det Matematisk-naturvitenskapelige Fakultet, Bergen, Norway
,
Ingfrid Salvesen Haldorsen
2   Department of Clinical Medicine, University of Bergen, Norway
,
Odd Helge Gilja
4   Department of Clinical Medicine, Universitetet i Bergen Det medisinsk-odontologiske fakultet, Bergen, Norway
,
Georg Dimcevski
1   Department of Medicine, Haukeland Universitetssjukehus, Bergen, Norway
,
Roald Flesland Havre
5   National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway
› Author Affiliations
Further Information

Publication History

19 December 2017

19 February 2018

Publication Date:
26 March 2018 (online)

Abstract

Purpose We aimed to evaluate the agreement of single criteria and dedicated scores from transabdominal ultrasound of the pancreas (US) compared to standards by endoscopic ultrasound (EUS) and computed tomography (CT).

Materials and Methods In this observational cohort study performed in a tertiary care center, US and EUS were performed in 110 patients referred for suspected CP. Based on the Mayo score, 52 patients were diagnosed with CP. The sonographic findings obtained by both methods were registered. The number of criteria was counted and scored according to the Rosemont score.

Results Agreement between the number of detected US and EUS criteria was substantial (ICC = 0.74 [0.61–0.83]. Adding Rosemont weighting improved the agreement (ICC = 0.88 [0.81–0.92]). Regarding individual criteria, the agreement was substantial for the detection of calcifications (κ = 0.86) and moderate for cysts and irregular or dilated pancreatic duct (κ = 0.42–0.58). Agreement for the other criteria was poorer (κ≤ 0.40). The diagnostic performance indices [95 % CI] of US for diagnosing CP (using Mayo score as reference standard) were for the unweighted score: Sensitivity: 0.65 [0.51–0.78], specificity: 0.97 [0.87–1.00]; and for Rosemont score: Sensitivity: 0.75 [0.61–0.86], specificity: 0.95 [0.83–0.99].

Conclusion The agreement between US and EUS for the unweighted and weighted scores was substantial. For the features calcifications, cysts and main pancreatic duct (MPD) changes, agreement was moderate to substantial. For the other detected US criteria, the agreement with EUS was too poor to be clinically relevant.

Zusammenfassung

Ziel Das Ziel bestand darin, die Übereinstimmung von Einzelkriterien und dedizierten Scores des transabdominalen Ultraschalls der Bauchspeicheldrüse (US) im Vergleich zu den Standards des endoskopischen Ultraschalls (EUS) und der Computertomografie (CT) zu bewerten.

Materialien und Methoden In dieser Beobachtungsstudie, die in einem tertiären Versorgungszentrum durchgeführt wurde, wurde bei 110 Patienten mit Verdacht auf chronische Pankreatitis (CP) US und EUS durchgeführt. Basierend auf dem Mayo-Score wurde bei 52 Patienten eine CP diagnostiziert. Die mit beiden Methoden erhobenen sonografischen Befunde wurden erfasst. Die Anzahl der Kriterien wurde bestimmt und mittels Rosemont-Score bewertet.

Ergebnisse Die Übereinstimmung zwischen der Anzahl der festgestellten US- und EUS- Kriterien war beträchtlich (ICC = 0,74 [0,61–0,83]. Durch die zusätzliche Rosemont-Gewichtung verbesserte sich die Übereinstimmung (ICC = 0,88 [0,81–0,92]). In Bezug auf die Einzelkriterien war die Übereinstimmung für den Nachweis von Verkalkungen beträchtlich (κ = 0,86) und von Zysten und eines irregulären oder dilatierten Pankreasgangs moderat (κ = 0,42–0,58). Die Übereinstimmung bezüglich der übrigen Kriterien war schlechter (κ ≤ 0,40). Die diagnostischen Leistungsindizes [95 % CI] des US für die Diagnose einer CP (mit Mayo-Score als Referenzstandard) betrugen für den ungewichteten Score: Sensitivität: 0,65 [0,51–0,78], Spezifität: 0,97 [0,87–1,00] und für den Rosemont-Score: Sensitivität: 0,75 [0,61–0,86], Spezifität: 0.95 [0.83–0.99].

Schlussfolgerung Die Übereinstimmung zwischen US und EUS bei den ungewichteten und gewichteten Scores war erheblich. Für die Merkmale Verkalkungen, Zysten und Veränderungen des Pankreashauptganges (MPD) war die Übereinstimmung moderat bis beträchtlich. Für die anderen festgestellten US-Kriterien, war die Übereinstimmung zu schlecht, um klinisch relevant zu sein.

 
  • References

  • 1 Conwell DL, Lee LS, Yadav D. et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas 2014; 43: 1143-1162
  • 2 Lohr JM, Dominguez-Munoz E, Rosendahl J. et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European gastroenterology journal 2017; 5: 153-199
  • 3 Foley WD, Stewart ET, Lawson TL. et al. Computed tomography, ultrasonography, and endoscopic retrograde cholangiopancreatography in the diagnosis of pancreatic disease: a comparative study. Gastrointest Radiol 1980; 5: 29-35
  • 4 Fontana G, Bolondi L, Conti M. et al. An evaluation of echography in the diagnosis of pancreatic disease. Gut 1976; 17: 228-234
  • 5 Gebel M, Stiehl M, Freise J. Value of sonographic imaging of the pancreatic duct for the diagnosis of chronic pancreatitis and pancreatic cancer compared to ERCP. Ultraschall in Med 1985; 6: 127-130
  • 6 Ikeda M, Sato T, Morozumi A. et al. Morphologic changes in the pancreas detected by screening ultrasonography in a mass survey, with special reference to main duct dilatation, cyst formation, and calcification. Pancreas 1994; 9: 508-512
  • 7 Lawson TL. Sensitivity of pancreatic ultrasonography in the detection of pancreatic disease. Radiology 1978; 128: 733-736
  • 8 Lutz H, Petzoldt R, Hofmann KP. et al. Efficacy of ultrasonography in pancreatic disorders compared to endoscopic retrograde pancreaticography (author’s transl). Klin Wochenschr 1975; 53: 419-424
  • 9 Whitsett MC. Ultrasound Imaging and Advances in System Features. Ultrasound Clinics. 7/1/2009 2009
  • 10 Erchinger F, Dimcevski G, Engjom T. et al. Transabdominal ultrasound of the Pancreas: Basic and new aspects. Imaging Med 2011; 3: 411-422
  • 11 Engjom T, Sangnes DA, Havre RF. et al. Diagnostic Accuracy of Transabdominal Ultrasound in Chronic Pancreatitis. Ultrasound in medicine & biology 2017; 43: 735-743
  • 12 Catalano MF, Lahoti S, Geenen JE. et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998; 48: 11-17
  • 13 Kalmin B, Hoffman B, Hawes R. et al. Conventional versus Rosemont endoscopic ultrasound criteria for chronic pancreatitis: comparing interobserver reliability and intertest agreement. Can J Gastroenterol 2011; 25: 261-264
  • 14 Luetmer PH, Stephens DH, Ward EM. Chronic pancreatitis: reassessment with current CT. Radiology 1989; 171: 353-357
  • 15 Pungpapong S, Wallace MB, Woodward TA. et al. Accuracy of endoscopic ultrasonography and magnetic resonance cholangiopancreatography for the diagnosis of chronic pancreatitis: a prospective comparison study. J Clin Gastroenterol 2007; 41: 88-93
  • 16 Sahai AV, Zimmerman M, Aabakken L. et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998; 48: 18-25
  • 17 Albashir S, Bronner MP, Parsi MA. et al. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am J Gastroenterol 2010; 105: 2498-2503
  • 18 Chong AK, Hawes RH, Hoffman BJ. et al. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest Endosc 2007; 65: 808-814
  • 19 Catalano MF, Sahai A, Levy M. et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc 2009; 69: 1251-1261
  • 20 Stevens T, Lopez R, Adler DG. et al. Multicenter comparison of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for diagnosis of chronic pancreatitis. Gastrointest Endosc 2010; 71: 519-526
  • 21 Erchinger F, Engjom T, Tjora E. et al. Quantification of pancreatic function using a clinically feasible short endoscopic secretin test. Pancreas 2013; 42: 1101-1106
  • 22 Layer P, Yamamoto H, Kalthoff L. et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481-1487
  • 23 Schreyer AG, Jung M, Riemann JF. et al. S3 guideline for chronic pancreatitis – diagnosis, classification and therapy for the radiologist. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2014; 186: 1002-1008
  • 24 Stevens T, Conwell DL, Zuccaro Jr G. et al. A prospective crossover study comparing secretin-stimulated endoscopic and Dreiling tube pancreatic function testing in patients evaluated for chronic pancreatitis. Gastrointest Endosc 2008; 67: 458-466
  • 25 Loser C, Mollgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 1996; 39: 580-586
  • 26 Cantor A. Sample-Size calculations for Cohens Kappa. Psychological Methods 1996; 1: 150-153
  • 27 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845
  • 28 Altman D. Practical statistics for medical Research. Chapter 14.3. Interrater agreement. 7 ed. London: Chapman & Hall; 1997
  • 29 World Medical Association General Assembly. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ Accessed December 13, 2017
  • 30 STARD Statement Standards for the Reporting of Diagnostic accuracy studies. 2014 Available at: http://www.stard-statement.org/ . Accessed December 13, 2017
  • 31 Lesniak RJ, Hohenwalter MD, Taylor AJ. Spectrum of causes of pancreatic calcifications. Am J Roentgenol 2002; 178: 79-86